table of content
1 Introduction to Research & Analysis Reports
1.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Overall Market Size
2.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size: 2022 VS 2029
2.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players in Global Market
3.2 Top Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies Ranked by Revenue
3.3 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
4.1.4 Entry and Fusion Inhibitors
4.1.5 Protease Inhibitors (PIs)
4.1.6 Integrase Inhibitors
4.1.7 Coreceptor Antagonists
4.2 By Type - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Labs
5.2 By Application - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2029
6.3.2 US Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.3.3 Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.3.4 Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2029
6.4.2 Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.3 France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.4 U.K. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.5 Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.6 Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.4.8 Benelux Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2029
6.5.2 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.5.3 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.5.4 South Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.5.6 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2029
6.6.2 Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.6.3 Argentina Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, 2018-2029
6.7.2 Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.7.3 Israel Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
6.7.5 UAE Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, 2018-2029
7 Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies Profiles
7.1 AbbVie, Inc.(U.S.)
7.1.1 AbbVie, Inc.(U.S.) Company Summary
7.1.2 AbbVie, Inc.(U.S.) Business Overview
7.1.3 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.1.4 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AbbVie, Inc.(U.S.) Key News & Latest Developments
7.2 Merck & Co., Inc. (U.S.)
7.2.1 Merck & Co., Inc. (U.S.) Company Summary
7.2.2 Merck & Co., Inc. (U.S.) Business Overview
7.2.3 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.2.4 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Merck & Co., Inc. (U.S.) Key News & Latest Developments
7.3 Bristol-Myers Squibb Company (U.S.)
7.3.1 Bristol-Myers Squibb Company (U.S.) Company Summary
7.3.2 Bristol-Myers Squibb Company (U.S.) Business Overview
7.3.3 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Company (U.S.) Key News & Latest Developments
7.4 Boehringer Ingelheim GmbH (Germany)
7.4.1 Boehringer Ingelheim GmbH (Germany) Company Summary
7.4.2 Boehringer Ingelheim GmbH (Germany) Business Overview
7.4.3 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim GmbH (Germany) Key News & Latest Developments
7.5 Genentech, Inc. (U.S.)
7.5.1 Genentech, Inc. (U.S.) Company Summary
7.5.2 Genentech, Inc. (U.S.) Business Overview
7.5.3 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.5.4 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Genentech, Inc. (U.S.) Key News & Latest Developments
7.6 Cipla, Inc. (India)
7.6.1 Cipla, Inc. (India) Company Summary
7.6.2 Cipla, Inc. (India) Business Overview
7.6.3 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Major Product Offerings
7.6.4 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Cipla, Inc. (India) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
